FDA approves Eli Lilly’s Olumiant oral tablets for alopecia
June 13, 2022 at 16:05 PM EDT
The U.S. Food and Drug Administration said Monday it approved Eli Lilly & Co.'s Olumiant oral tablets to treat adults with severe alopecia areata.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|